Treatment of advanced Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Treatment of advanced Parkinson's disease.

Treatment of advanced Parkinson's disease.

http://www.wikidata.org/entity/Q55645561

about

Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation An update on the diagnosis and treatment of Parkinson disease Technology-aided leisure and communication: Opportunities for persons with advanced Parkinson's disease.Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.Cognitive and Psychiatric Effects of STN versus GPi Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson's disease: involvement of the PI3K/Akt/mTOR pathway.Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease.Modified biomolecule as potential vehicle for buccal delivery of doxepin.Glucose-6-phosphatase-α participates in dopaminergic differentiation.Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease.A randomized, fixed-dose, dose-response study of ropinirole prolonged release in advanced Parkinson's disease.

P2860

Q26745654-53C0101E-81C8-4819-BC7B-A5B38EE978C0 Q30243899-BA457426-2327-415A-B868-B8116EB70F77 Q30373261-A959CC61-5E37-487F-9643-3A8829A6ED62 Q34534818-C6B2E156-87D6-44E3-B505-CA2CF686E097 Q36036036-A99037CC-3ADD-4ED3-B544-54147D4B5CAF Q37664213-90FF804C-B498-4F6E-96FB-C530A3F322B1 Q42363015-1667089F-6D63-4094-B7D6-4EABD363F1CB Q47276206-41D0187D-323C-4C51-B49D-2E40A5AEC339 Q47800117-69282C95-7361-4F35-8C83-73DE8B5F8B56 Q47922279-F0E12797-8788-480E-9CB2-0880C4865053 Q48224687-3B06735B-F669-4CD1-A873-36AEB2BCFE5E Q50933626-DA35F36B-C0CA-49B5-A4B7-D82DD41C377D

P2860

Treatment of advanced Parkinson's disease.

http://www.wikidata.org/entity/Q55645561

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Treatment of advanced Parkinson's disease.

@en

Treatment of advanced Parkinson's disease.

@nl

type

label

Treatment of advanced Parkinson's disease.

@en

Treatment of advanced Parkinson's disease.

@nl

prefLabel

Treatment of advanced Parkinson's disease.

@en

Treatment of advanced Parkinson's disease.

@nl

P1433

Q55645561-DE737D0D-982C-4605-AB37-07BBE8C02DDD

P1476

Q55645561-68F950FB-D95F-446B-9A71-98CD5DE5157C

P2093

Q55645561-342C85FC-BDEA-4862-8681-CA8AE9B156DF

P2860

Q55645561-0022B60F-EED3-421C-B88D-FB26A053AC82

Q55645561-01183A0F-D86A-4A34-A834-D74CB48C3417

Q55645561-013DCEB0-FCC5-4556-9DD8-EBB7DD16ABC7

Q55645561-02095A99-5754-40CC-80E6-ED35A03F66C7

Q55645561-022BF76F-F8F1-46C2-833E-E5455FE1F82A

Q55645561-03FA2BA7-3D7B-4A1F-9771-F47C264D986B

Q55645561-063529BB-2691-4016-8BD5-51C776521DC5

Q55645561-09C2D850-875F-4EDA-A4C7-ED7647646629

Q55645561-0CBB370D-7E52-4517-8841-9D4C1CF582BC

Q55645561-0CC82D91-6B6B-46E9-868C-134B07EE975C

P304

Q55645561-C6BAC6BC-4ECA-447E-82C1-92FD723B5758

P31

Q55645561-5614A051-EA77-4DDB-A8A1-085BC61735CE

P356

Q55645561-68930ACF-6356-42FE-889A-ACF82E24DFDF

P433

Q55645561-6CAADF41-7B72-41F8-844A-A8CD91E42652

P478

Q55645561-96A0B64A-CFF6-4584-936C-992E5AEBB5B1

P50

Q55645561-E8BDF386-1350-416A-8523-9AC5EBB925D9

P577

Q55645561-6533D43C-0C41-499B-AD28-CD07B21715AC

P698

Q55645561-14621E36-5C6B-4E45-9692-3293B6042C19

P921

Q55645561-7275C762-9B64-455B-A839-2D03FB151ADD

P932

Q55645561-29CD47E9-307D-4136-8C48-208593B21428

P356

WCO.0000000000000118

P1433

Current Opinion in Neurology

P1476

Treatment of advanced Parkinson's disease.

@en

P2093

Juan C Giugni

http://www.w3.org/2001/XMLSchema#string

P2860

Rationale and clinical pearls for primary care doctors referring patients for deep brain stimulation

Outcomes of rotigotine clinical trials: effects on motor and nonmotor symptoms of Parkinson's disease

Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease

Parkinsonism: onset, progression and mortality

Treatment of psychosis and dementia in Parkinson's disease.

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation

Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial.

P304

450-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WCO.0000000000000118

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Okun

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24978634

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4140171

http://www.w3.org/2001/XMLSchema#string